J&J | JNJ - Equity Capital And Reserves


J&J reported $84.97B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -5.94B 721M Jun/2026
Abbott USD 52.06B 69M Mar/2026
Amgen USD 11.69B 2.5B Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Bayer EUR 29.71B 863M Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
Boston Scientific USD 24.93B 934M Jun/2026
Bristol-Myers Squibb USD 22.32B 2.25B Jun/2026
CONMED USD 1.04B 23.72M Jun/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.62B 335.5M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Eli Lilly USD 33.88B 2.68B Jun/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Globus Medical USD 4.77B 36.29M Jun/2026
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Medtronic USD 50.07B 1.09B Mar/2026
Merck USD 41.93B 3.94B Jun/2026
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Pfizer USD 85.19B 4.91B Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 130.39M 2.02M Jun/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026
Vertex Pharmaceuticals USD 20.25B 886M Jun/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026
Zoetis USD 3.15B 85M Jun/2026